Merck registers two new Phase 1/2 trials; KEYVIBE-005 results remain on recordSep 30Weekly roundup, 4 itemsMerck & Co., Inc.pembrolizumabUpdated
FDA clears two Welireg supplements for Merck's belzutifan, both approved September 24, 2026Sep 24Regulatory decisionbelzutifanMerck & Co., Inc.
Merck registers Phase 3 sotatercept HFpEF trial; Terns completes two TERN-701 Phase 1 studiesSep 24Weekly roundup, 3 itemsMerck & Co., Inc.sotatercept-csrk
Novartis-linked melanoma trial posts results; new ITP preference survey and LASIK study activeAug 27Weekly roundup, 4 itemsdabrafenibitraconazole
NIAID-led IMPAACT 2026 pharmacokinetic study terminated early, results postedAug 26Trial updateGilead SciencesGlaxoSmithKline
Lilly registers Phase 3 depression trial; posts results for two psoriasis and oncology studiesAug 20Weekly roundup, 5 itemsabemaciclibbrenipatide
Merck registers Phase 3 trial testing R-DXd maintenance in advanced ovarian cancerAug 20Trial updateDaiichi SankyoMerck & Co., Inc.
Olaparib Phase 2 results posted; three diabetes labels updated; new myeloma CAR-T trial recruitsAug 14Weekly roundup, 9 itemsAstraZenecaAZD0120
NextCure's NC410-pembrolizumab trial ends after Phase 1b; Part 2 never launchedAug 13Trial updateMerck & Co., Inc.NC410
Merck posts three JANUMET-family label updates; TERN-601 obesity data still stands outAug 11Weekly roundup, 4 itemsertugliflozin and metformin hydrochlorideMerck & Co., Inc.
Exelixis registers Phase 3 STELLAR-316 trial of zanzalintinib in colorectal cancer MRDAug 6Trial updateExelixisMerck & Co., Inc.
Exelixis Q2 2026 results detail zanzalintinib pipeline progress, narrows guidanceAug 5Quarterly updateExelixisMerck & Co., Inc.
Merck posts Q2 loss on Terns charge, raises full-year sales outlookAug 4Quarterly updateMerck & Co., Inc.
Merck registers Phase 2/3 trial of bomedemstat versus standard therapies in polycythemia veraJul 23Trial updateMerck & Co., Inc.
Merck registers Phase 2 MK-1045 trial in B-cell cancers; letermovir CMV study also listedJul 16Weekly roundup, 4 itemsafliberceptletermovir
Sign in